Joel Cassel

2.2k total citations
69 papers, 1.3k citations indexed

About

Joel Cassel is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Joel Cassel has authored 69 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 24 papers in Cellular and Molecular Neuroscience and 10 papers in Pharmacology. Recurrent topics in Joel Cassel's work include Neuropeptides and Animal Physiology (20 papers), Receptor Mechanisms and Signaling (19 papers) and Pharmacological Receptor Mechanisms and Effects (14 papers). Joel Cassel is often cited by papers focused on Neuropeptides and Animal Physiology (20 papers), Receptor Mechanisms and Signaling (19 papers) and Pharmacological Receptor Mechanisms and Effects (14 papers). Joel Cassel collaborates with scholars based in United States, Cameroon and Germany. Joel Cassel's co-authors include Robert N. DeHaven, Jeffrey D. Daubert, Allen B. Reitz, Diane L. DeHaven‐Hudkins, Erik Mansson, Tony L. Yaksh, Joseph M. Salvino, Roland E. Dolle, Mark E. McDonnell and Murray Goodman and has published in prestigious journals such as Nature, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Joel Cassel

63 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joel Cassel United States	22	772	359	181	168	147	69	1.3k
James Ziogas Australia	21	750 1.0×	331 0.9×	91 0.5×	200 1.2×	85 0.6×	60	1.5k
W. Christian Wigley United States	22	1.5k 1.9×	167 0.5×	112 0.6×	220 1.3×	63 0.4×	35	2.0k
Nir Qvit United States	17	1.4k 1.8×	165 0.5×	119 0.7×	242 1.4×	72 0.5×	45	1.8k
Corinne E. Augelli‐Szafran United States	21	599 0.8×	175 0.5×	78 0.4×	144 0.9×	45 0.3×	62	1.1k
Andrea E. DeBarber United States	23	777 1.0×	117 0.3×	254 1.4×	196 1.2×	42 0.3×	49	1.8k
Carlo Farina Italy	22	746 1.0×	187 0.5×	149 0.8×	134 0.8×	48 0.3×	45	1.3k
Ganta Vijay Chaitanya United States	16	613 0.8×	88 0.2×	276 1.5×	89 0.5×	94 0.6×	18	1.2k
Mark Namchuk United States	17	1.0k 1.3×	135 0.4×	94 0.5×	82 0.5×	78 0.5×	29	1.7k
Erich L. Grimm Canada	19	703 0.9×	220 0.6×	125 0.7×	83 0.5×	133 0.9×	39	1.7k

Countries citing papers authored by Joel Cassel

Since Specialization

Citations

This map shows the geographic impact of Joel Cassel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Cassel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Cassel more than expected).

Fields of papers citing papers by Joel Cassel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Cassel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Cassel. The network helps show where Joel Cassel may publish in the future.

Co-authorship network of co-authors of Joel Cassel

This figure shows the co-authorship network connecting the top 25 collaborators of Joel Cassel. A scholar is included among the top collaborators of Joel Cassel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Cassel. Joel Cassel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mirji, Gauri, Sidra Islam, Lacy M. Simons, et al.. (2025). Targeting Interactions Between Siglec-10 and α3β1 Integrin Enhances Macrophage-Mediated Phagocytosis of Pancreatic Cancer. Cancer Research. 86(1). 99–115.

Simoben, Conrad V., Mustafa Alhaji Isa, Adi Narayana Reddy Poli, et al.. (2024). 5-chloro-3-(2-(2,4-dinitrophenyl) hydrazono)indolin-2-one: synthesis, characterization, biochemical and computational screening against SARS-CoV-2. Chemical Papers. 78(6). 3431–3441. 5 indexed citations

Cassel, Joel, Conrad V. Simoben, Ian Tietjen, et al.. (2024). Design, synthesis, and biochemical and computational screening of novel oxindole derivatives as inhibitors of Aurora A kinase and SARS-CoV-2 spike/host ACE2 interaction. Medicinal Chemistry Research. 33(4). 620–634. 4 indexed citations

Cassel, Joel, Joseph M. Salvino, Luis J. Montaner, et al.. (2024). Drug repositioning identifies salvinorin A and deacetylgedunin (DCG) enriched plant extracts as novel inhibitors of Mpro, RBD–ACE2 and TMPRRS2 proteins. RSC Advances. 14(29). 21203–21212. 1 indexed citations

Cassel, Joel, et al.. (2024). Synthesis, SARS-CoV-2 main protease inhibition, molecular docking and in silico ADME studies of furanochromene-quinoline hydrazone derivatives. Bioorganic & Medicinal Chemistry Letters. 102. 129679–129679. 2 indexed citations

Cui, Yange, Luyang Wang, Qingbao Ding, et al.. (2023). Elevated pre-mRNA 3′ end processing activity in cancer cells renders vulnerability to inhibition of cleavage and polyadenylation. Nature Communications. 14(1). 4480–4480. 10 indexed citations

Adams, Clare M., Ramkrishna Mitra, You‐Cai Xiao, et al.. (2023). Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer. Cancer Discovery. 13(5). 1210–1229. 57 indexed citations

Poli, Adi Narayana Reddy, Eric Tang, Joel Cassel, et al.. (2023). Synthesis and characterization of I-BET151 derivatives for use in identifying protein targets in the African trypanosome. PubMed. 3. 100047–100047. 1 indexed citations

Moyo, Phanankosi, Joel Cassel, Joseph M. Salvino, et al.. (2022). Use of hyphenated analytical techniques to identify the bioactive constituents of Gunnera perpensa L., a South African medicinal plant, which potently inhibit SARS-CoV-2 spike glycoprotein–host ACE2 binding. Analytical and Bioanalytical Chemistry. 414(13). 3971–3985. 11 indexed citations

10.

Miller, Katelyn D., Caroline Perry, Y. V. V. Srikanth, et al.. (2021). Targeting ACSS2 with a Transition-State Mimetic Inhibits Triple-Negative Breast Cancer Growth. Cancer Research. 81(5). 1252–1264. 67 indexed citations

11.

Peng, Hongzhuang, Joel Cassel, Jeremy W. Prokop, et al.. (2021). Kinetic Characterization of ASXL1/2-Mediated Allosteric Regulation of the BAP1 Deubiquitinase. Molecular Cancer Research. 19(7). 1099–1112. 4 indexed citations

12.

Zundell, Joseph A., Takeshi Fukumoto, Jianhuang Lin, et al.. (2021). Targeting the IRE1α/XBP1 Endoplasmic Reticulum Stress Response Pathway in ARID1A -Mutant Ovarian Cancers. Cancer Research. 81(20). 5325–5335. 22 indexed citations

13.

Coyne, Alyssa N., Shizuka Yamada, Patricia S. Estes, et al.. (2015). Fragile X protein mitigates TDP-43 toxicity by remodeling RNA granules and restoring translation. Human Molecular Genetics. 24(24). ddv389–ddv389. 64 indexed citations

14.

Cassel, Joel, Benjamin E. Blass, Allen B. Reitz, & Aaron C. Pawlyk. (2010). Development of a Novel Nonradiometric Assay for Nucleic Acid Binding to TDP-43 Suitable for High-Throughput Screening Using AlphaScreen® Technology. SLAS DISCOVERY. 15(9). 1099–1106. 24 indexed citations

15.

Worm, Karin, Christopher T. Saeui, Joel Cassel, et al.. (2009). Discovery of N-(3-(morpholinomethyl)-phenyl)-amides as potent and selective CB2 agonists. Bioorganic & Medicinal Chemistry Letters. 19(17). 5004–5008. 6 indexed citations

16.

Chu, Guo‐Hua, Bertrand Le Bourdonnec, Minghua Gu, et al.. (2009). Design and Synthesis of Imidazopyrimidine Derivatives as Potent iNOS Dimerization Inhibitors. PubMed. 3(1). 8–13. 8 indexed citations

17.

Bourdonnec, Bertrand Le, Karin Worm, Catherine Goodman, et al.. (2009). Novel sulfamoyl benzamides as selective CB2 agonists with improved in vitro metabolic stability. Bioorganic & Medicinal Chemistry Letters. 20(1). 387–391. 9 indexed citations

18.

Kumar, Virendra, Jeffrey D. Daubert, Joel Cassel, et al.. (2005). Amino acid conjugates as κ opioid receptor agonists. Bioorganic & Medicinal Chemistry Letters. 15(5). 1279–1282. 2 indexed citations

19.

Dolle, Roland E., Blanca Martínez‐Teipel, Serge Belanger, et al.. (2004). (4-Carboxamido)phenylalanine is a surrogate for tyrosine in opioid receptor peptide ligands. Bioorganic & Medicinal Chemistry Letters. 14(13). 3545–3548. 21 indexed citations

20.

Bourdonnec, Bertrand Le, et al.. (2003). trans -3,4-Dimethyl-4-(3-carboxamidophenyl)piperidines: A novel class of μ-Selective opioid antagonists. Bioorganic & Medicinal Chemistry Letters. 13(24). 4459–4462. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact